Abstract 5881: Transcriptomic profiling of extracellular vesicle subpopulations enables liquid biopsy-based brain tumor classification

Abstract Liquid biopsies based on circulating tumor-derived cell-free DNA (ctDNA) have become an increasingly common tool for minimally invasive diagnostic testing. However, as ctDNA does not easily cross the blood-brain barrier, cell-free DNA tests for identifying and classifying brain tumors are of limited utility. Extracellular vesicles (EVs), which carry heterogeneous protein, nucleic acid, and metabolite cargos derived from various cell types including cancer cells, are an attractive alternative to ctDNA that can cross the blood-brain barrier. Because only a small fraction of circulating EVs are derived from diseased cells, current EV-based methods for cancer detection often suffer from low signal-to-noise ratios. To circumvent this issue, we have developed an extracellular vesicle subpopulation enrichment technology that specifically targets EVs derived from diseased cells. EV subpopulation transcriptomics interrogated using machine learning and gene network analyses can distinguish healthy patients, patients with benign tumors, and patients with glioma. Known tissue markers as well as novel features provide the basis for patient stratification. Coupled with a state-of-the-art multi-omics workflow, our novel EV enrichment platform allows us to capitalize upon the powerful diagnostic information contained within EV subpopulations to identify and characterize cancers from standard blood plasma samples. Citation Format: Margie Kinnersley, Claire Seibold, Tre Blohm, Riley Kemp, Sean Lodmell, Amanda Mast, Tia Seibold, Rachel Short Miller, Kelley Van Vaerenberghe, Katie Havranek. Transcriptomic profiling of extracellular vesicle subpopulations enables liquid biopsy-based brain tumor classification [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5881.

Authors

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-5881
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 5881: Transcriptomic profiling of extracellular vesicle subpopulations enables liquid biopsy-based brain tumor classification

Margie Kinnersley, A Mast, ROBERT COLEMAN KEMP, Thomas R. Blohm et al.
2 links
Cancer Research
Extracellular vesicles in disease
article

Abstract 5881: Transcriptomic profiling of extracellular vesicle subpopulations enables liquid biopsy-based brain tumor classification

Margie Kinnersley, A Mast, ROBERT COLEMAN KEMP, Thomas R. Blohm, Katie Havranek, Rachel J. Miller, Claire Seibold, Tia Seibold, Kelley Van Vaerenberghe, Sean Lodmell
article en

Abstract

Abstract Liquid biopsies based on circulating tumor-derived cell-free DNA (ctDNA) have become an increasingly common tool for minimally invasive diagnostic testing. However, as ctDNA does not easily cross the blood-brain barrier, cell-free DNA tests for identifying and classifying brain tumors are of limited utility. Extracellular vesicles (EVs), which carry heterogeneous protein, nucleic acid, and metabolite cargos derived from various cell types including cancer cells, are an attractive alternative to ctDNA that can cross the blood-brain barrier. Because only a small fraction of circulating EVs are derived from diseased cells, current EV-based methods for cancer detection often suffer from low signal-to-noise ratios. To circumvent this issue, we have developed an extracellular vesicle subpopulation enrichment technology that specifically targets EVs derived from diseased cells. EV subpopulation transcriptomics interrogated using machine learning and gene network analyses can distinguish healthy patients, patients with benign tumors, and patients with glioma. Known tissue markers as well as novel features provide the basis for patient stratification. Coupled with a state-of-the-art multi-omics workflow, our novel EV enrichment platform allows us to capitalize upon the powerful diagnostic information contained within EV subpopulations to identify and characterize cancers from standard blood plasma samples. Citation Format: Margie Kinnersley, Claire Seibold, Tre Blohm, Riley Kemp, Sean Lodmell, Amanda Mast, Tia Seibold, Rachel Short Miller, Kelley Van Vaerenberghe, Katie Havranek. Transcriptomic profiling of extracellular vesicle subpopulations enables liquid biopsy-based brain tumor classification [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5881.

Cancer ResearchVol. 85(8_Supplement_1)
Openalex Percentile: Top 93%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.